In human atherosclerotic lesions, PPARγ activation has been reported to promote differentiation of proatherogenic M1 macrophages into an alternative anti-inflammatory phenotype, M2, which could protect against the development of atherosclerosis. This evidence concerns the gene PPARG and atherosclerosis.